4.7 Article

Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity

期刊

PEDIATRICS
卷 140, 期 5, 页码 -

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2017-1305

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Disease [DK 63829, 63861, 63821, 63865, 63863, 63836, 63790, UC4DK095300, HHSN267200700014C]
  2. NIH/NCATS Clinical and Translational Science Awards [UL1 TR000064]
  3. University of Colorado [UL1 TR001082]
  4. National Institutes of Health (NIH)
  5. [U01 DK63829]
  6. [U01 DK63861]
  7. [U01 DK63821]
  8. [U01 DK63865]
  9. [U01 DK63863]
  10. [U01 DK63836]
  11. [U01 DK63790]
  12. [UC4 DK63829]
  13. [UC4 DK63861]
  14. [UC4 DK63821]
  15. [UC4 DK63865]
  16. [UC4 DK63863]
  17. [UC4 DK63836]
  18. [UC4 DK95300]
  19. [UC4 DK100238]
  20. [UC4 DK106955]

向作者/读者索取更多资源

BACKGROUND AND OBJECTIVES: Few birth cohorts have prospectively followed development of type 1 diabetes (T1D) and celiac disease (CD) autoimmunities to determine timing, extent of co-occurrence, and associated genetic and demographic factors. METHODS: In this prospective birth cohort study, 8676 children at high genetic risk of both diseases were enrolled and 5891 analyzed in median follow-up of 66 months. Along with demographic factors and HLA-DR-DQ, genotypes for HLA-DPB1 and 5 non-HLA loci conferring risk of both T1D and CD were analyzed. RESULTS: Development of persistent islet autoantibodies (IAs) and tissue transglutaminase autoantibodies (tTGAs), as well as each clinical disease, was evaluated quarterly from 3 to 48 months of age and semiannually thereafter. IAs alone appeared in 367, tTGAs alone in 808, and both in 90 children. Co-occurrence significantly exceeded the expected rate. IAs usually, but not always, appeared earlier than tTGAs. IAs preceding tTGAs was associated with increasing risk of tTGAs (hazard ratio [HR]: 1.48; 95% confidence interval [CI]: 1.151.91). After adjusting for country, sex, family history, and all other genetic loci, significantly greater co-occurrence was observed in children with a T1D family history (HR: 2.80), HLA-DR3/ 4 (HR: 1.94) and single-nucleotide polymorphism rs3184504 at SH2B3 (HR: 1.53). However, observed co-occurrence was not fully accounted for by all analyzed factors. CONCLUSIONS: In early childhood, T1D autoimmunity usually precedes CD autoimmunity. Preceding IAs significantly increases the risk of subsequent tTGAs. Co-occurrence is greater than explained by demographic factors and extensive genetic risk loci, indicating that shared environmental or pathophysiological mechanisms may contribute to the increased risk.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Incidence of Pediatric Celiac Disease Varies by Region

Marisa Stahl, Qian Li, Kristian Lynch, Sibylle Koletzko, Pooja Mehta, Loren Gragert, Jill M. Norris, Carin Andren Aronsson, Katri Lindfors, Kalle Kurppa, Jorma Ilonen, Jeffrey Krischer, Beena Alkolkar, Anette-G Ziegler, Jorma Toppari, Marian J. Rewers, Daniel Agardh, William Hagopian, Edwin Liu, TEDDY Study Grp

Summary: The study examines regional differences in celiac disease (CD) development among children in Europe and the United States. The incidence of CD varied by region, with Swedish children having the highest incidence at 3%. In the United States, the incidence was highest in Colorado at 2.4%.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Endocrinology & Metabolism

Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5-to 15-Year-Old Children Followed in the TEDDY Study

Xiang Liu, Suzanne Bennett Johnson, Kristian F. Lynch, Kerry Cordan, Russell Pate, Martha D. Butterworth, Ake Lernmark, William A. Hagopian, Marian J. Rewers, Richard A. McIndoe, Jorma Toppari, Anette-G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Jimin Yang, TEDDY Study Grp

Summary: This study found that increasing the daily duration of moderate to vigorous physical activity can reduce the risk of developing type 1 diabetes in children aged 5-15 who have multiple islet autoantibodies.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study

Steffen U. Thorsen, Xiang Liu, Yachana Kataria, Thomas Mandrup-Poulsen, Simranjeet Kaur, Ulla Uusitalo, Suvi M. Virtanen, Jill M. Norris, Marian Rewers, William Hagopian, Jimin Yang, Jin-Xiong She, Beena Akolkar, Stephen Rich, Carin Andren Aronsson, Ake Lernmark, Anette-Gabriele Ziegler, Jorma Toppari, Jeffrey Krischer, Hemang M. Parikh, Christina Ellervik, Jannet Svensson

Summary: It is found that iron intake and genetically determined iron overload may interact in predisposing to the development of childhood islet autoimmunity and type 1 diabetes. A U-shaped association between iron intake and risk of GAD antibody as the first autoantibody in children was found. High iron intake was associated with an increased risk of IA with insulin as the first autoantibody in children with 2 or more iron risk alleles.

DIABETES CARE (2023)

Review Medicine, General & Internal

Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes

Ake Lernmark, Beena Akolkar, William Hagopian, Jeffrey Krischer, Richard McIndoe, Marian Rewers, Jorma Toppari, Kendra Vehik, Anette-G. Ziegler, TEDDY Study Grp

Summary: The etiology of type 1 diabetes involves pancreatic islet beta-cell autoimmune pathogenesis that leads to the clinical onset of the disease. By testing autoantibodies against insulin, glutamic acid decarboxylase, islet antigen-2, and ZnT8 transporter, children can be monitored from birth until the appearance of the first islet autoantibody. The incidence rate of the first-appearing autoantibody follows two different patterns, and an innate immune reaction may precede the adaptive response.

JOURNAL OF INTERNAL MEDICINE (2023)

Review Gastroenterology & Hepatology

The role of gluten challenge in the diagnosis of celiac disease: a review

Alina Popp, Pilvi Laurikka, Diana Czika, Kalle Kurppa

Summary: Duodenal biopsy is the best method for diagnosing celiac disease, but there is increasing use of serology. Gluten challenge may be necessary if a person has reduced gluten intake before diagnosis. The optimal protocol for the challenge is still unclear.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Endocrinology & Metabolism

Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents

Hanna Riekki, Linnea Aitokari, Laura Kivela, Siiri Lahti, Pauliina Hiltunen, Nina Vuorela, Heini Huhtala, Timo A. Lakka, Kalle Kurppa

Summary: This study investigated the prevalence, risk factors, and metabolic co-morbidities of metabolic-associated fatty liver disease (MAFLD) in overweight children. The prevalence of MAFLD was 15%, with higher rates in boys than girls, and was associated with gender, puberty stage, disturbances in glucose and lipid metabolism, age, and BMI.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Gastroenterology & Hepatology

Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease

Iida Ahonen, Pilvi Laurikka, Sara Koskimaa, Heini Huhtala, Katri Lindfors, Katri Kaukinen, Kalle Kurppa, Laura Kivela

Summary: Vomiting and nausea appear to be specific symptoms associated with gluten ingestion in treated celiac disease. However, the overall prevalence and factors related to these symptoms during chronic gluten exposure and acute re-exposure remain unclear.

BMC GASTROENTEROLOGY (2023)

Article Oncology

Associations between Ambient Air Pollutants and Clonal Hematopoiesis of Indeterminate Potential

Claire L. Leiser, Eric A. Whitsel, Alexander Reiner, Stephen S. Rich, Jerome I. Rotter, Kent D. Taylor, Russel P. Tracy, Charles Kooperberg, Albert Vernon Smith, JoAnn E. Manson, Josyf C. Mychaleckyj, Alexander G. Bick, Adam A. Szpiro, Joel D. Kaufman

Summary: This study aimed to estimate the association between air pollution and clonal hematopoiesis of indeterminate potential (CHIP). The results showed no evidence of an association between air pollution and CHIP prevalence in two large observational cohorts.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Editorial Material Medical Laboratory Technology

Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This article summarizes the scientific evidence and recommendations for laboratory tests used in the diagnosis and management of patients with diabetes mellitus. The quality of the evidence supporting these tests varies, so an expert committee evaluated and compiled evidence-based recommendations. The guidelines were reviewed and revised based on feedback from reviewers and the public. They were then reviewed and approved by multiple professional organizations.

CLINICAL CHEMISTRY (2023)

Article Medical Laboratory Technology

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This passage discusses the use of laboratory tests in the diagnosis and management of diabetes mellitus, and provides evidence-based recommendations for laboratory analysis in screening, diagnosis, or monitoring of diabetes.

CLINICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This article provides evidence-based recommendations for laboratory analysis in patients with diabetes, including diagnostic methods, monitoring of glycemic control, and measurement of other related markers. The recommendations are based on published data or expert consensus.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

HLA Genotype and Probiotics Modify the Association Between Timing of Solid Food Introduction and Islet Autoimmunity in the TEDDY Study

Ulla Uusitalo, Lazarus K. Mramba, Carin Andren Aronsson, Kendra Vehik, Jimin Yang, Sandra Hummel, Ake Lernmark, Marian Rewers, William Hagopian, Richard Mcindoe, Jorma Toppari, Anette-G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Suvi M. Virtanen, Jill M. Norris, TEDDY Study Grp

Summary: This study aimed to investigate the interaction among HLA genotype, early probiotic exposure, and timing of complementary foods in relation to the risk of islet autoimmunity (IA). The results showed that early introduction of solid foods (<6 months) was associated with increased IA risk in children with the HLA DR3/4 genotype and no probiotic exposure during the first year of life. Introducing rice at 4-5.9 months, compared to other time periods in the US, was also associated with an increased risk of IA.

DIABETES CARE (2023)

Letter Medicine, General & Internal

SARS-CoV-2-No Increased Islet Autoimmunity or Type 1 Diabetes in Teens

Jeffrey P. Krischer, Ake Lernmark, William A. Hagopian, Marian J. Rewers, Richard McIndoe, Jorma Toppari, Anette-Gabriele Ziegler, Beena Akolkar

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Gastroenterology & Hepatology

Trends in the prevalence rates and predictive factors of coeliac disease: A long-term nationwide follow-up study

Juha Taavela, Kalle Kurppa, Tuija Jaaskelainen, Niina E. Kaartinen, Harri Rissanen, Heini Huhtala, Markku Maki, Katri Kaukinen

Summary: The prevalence of coeliac disease in Finland has been increasing over the years, with positive TGA without EmA, TGA values in the upper normal range, and pre-existing autoimmune diseases as predictors of developing the disease.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Review Medicine, Research & Experimental

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Jamie L. Felton, Kurt J. Griffin, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Andrea K. Steck, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, Stephen Gitelman, John M. Wentworth, Maria J. Redondo, Emily K. Sims

Summary: This article provides an overview of T1D disease modifying therapies and features linked to treatment response through a systematic review of randomized-controlled trials. The quality of prevention and intervention trials is generally high, but the quality of precision analyses is low, and certain factors should be considered in future trial designs.

COMMUNICATIONS MEDICINE (2023)

暂无数据